Bujard H - Search Results

1

High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation.

Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi BZ, Barshack I, Kopolovic J, Galun E, Bujard H, Ben-Neriah Y. Lavon I, et al. Among authors: bujard h. Nat Med. 2000 May;6(5):573-7. doi: 10.1038/75057. Nat Med. 2000. PMID: 10802715

2

IKK mediates ischemia-induced neuronal death.

Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, Malfertheiner M, Köhrmann M, Potrovita I, Maegele I, Beyer C, Burke JR, Hasan MT, Bujard H, Wirth T, Pasparakis M, Schwaninger M. Herrmann O, et al. Among authors: bujard h. Nat Med. 2005 Dec;11(12):1322-9. doi: 10.1038/nm1323. Epub 2005 Nov 13. Nat Med. 2005. PMID: 16286924

3

An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice.

Traykova-Brauch M, Schönig K, Greiner O, Miloud T, Jauch A, Bode M, Felsher DW, Glick AB, Kwiatkowski DJ, Bujard H, Horst J, von Knebel Doeberitz M, Niggli FK, Kriz W, Gröne HJ, Koesters R. Traykova-Brauch M, et al. Among authors: bujard h. Nat Med. 2008 Sep;14(9):979-84. doi: 10.1038/nm.1865. Nat Med. 2008. PMID: 18724376 Free PMC article.

4

Functional fluorescent Ca2+ indicator proteins in transgenic mice under TET control.

Hasan MT, Friedrich RW, Euler T, Larkum ME, Giese G, Both M, Duebel J, Waters J, Bujard H, Griesbeck O, Tsien RY, Nagai T, Miyawaki A, Denk W. Hasan MT, et al. Among authors: bujard h. PLoS Biol. 2004 Jun;2(6):e163. doi: 10.1371/journal.pbio.0020163. Epub 2004 Jun 15. PLoS Biol. 2004. PMID: 15208716 Free PMC article.

5

Stringent doxycycline dependent control of CRE recombinase in vivo.

Schönig K, Schwenk F, Rajewsky K, Bujard H. Schönig K, et al. Among authors: bujard h. Nucleic Acids Res. 2002 Dec 1;30(23):e134. doi: 10.1093/nar/gnf134. Nucleic Acids Res. 2002. PMID: 12466566 Free PMC article.

6

Generating conditional mouse mutants via tetracycline-controlled gene expression.

Schönig K, Bujard H. Schönig K, et al. Among authors: bujard h. Methods Mol Biol. 2003;209:69-104. doi: 10.1385/1-59259-340-2:69. Methods Mol Biol. 2003. PMID: 12357963 No abstract available.

7

Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.

Ueberham E, Löw R, Ueberham U, Schönig K, Bujard H, Gebhardt R. Ueberham E, et al. Among authors: bujard h. Hepatology. 2003 May;37(5):1067-78. doi: 10.1053/jhep.2003.50196. Hepatology. 2003. PMID: 12717387

8

Use of the tetracycline system for inducible protein synthesis in the kidney.

Gallagher AR, Schönig K, Brown N, Bujard H, Witzgall R. Gallagher AR, et al. Among authors: bujard h. J Am Soc Nephrol. 2003 Aug;14(8):2042-51. doi: 10.1097/01.asn.0000079615.38843.4a. J Am Soc Nephrol. 2003. PMID: 12874458

9

The power of reversibility regulating gene activities via tetracycline-controlled transcription.

Schönig K, Bujard H, Gossen M. Schönig K, et al. Among authors: bujard h. Methods Enzymol. 2010;477:429-53. doi: 10.1016/S0076-6879(10)77022-1. Methods Enzymol. 2010. PMID: 20699154

10

Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice.

Dumortier J, Schönig K, Oberwinkler H, Löw R, Giese T, Bujard H, Schirmacher P, Protzer U. Dumortier J, et al. Among authors: bujard h. Gene Ther. 2005 Apr;12(8):668-77. doi: 10.1038/sj.gt.3302449. Gene Ther. 2005. PMID: 15647761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters